Pharmaceutical Development and Technology · 2002 · 12 citations · 10 references
Natural SciencesBiochemistryMaterials ScienceBiomaterialsInorganic ChemistrySurface ScienceAluminum HydroxidesAluminum OxidesProtein AdsorptionProtein StabilizationAdsorption CapacityAluminum AdjuvantsAmorphous Aluminum HydroxideAmorphous Aluminum OxidesProtein Adsorption AnalysisRoom-temperature StorageSurface AreaThermal Treatment
Six aluminum hydroxide adjuvants, poorly crystalline aluminum oxyhydroxide (AlOOH) were prepared using different thermal treatments of amorphous aluminum hydroxide (Al(OH)3) in an effort to increase the protein adsorption capacity. All of the adjuvants initially exhibited a higher protein adsorption capacity. However, the protein adsorption capacity decreased during aging at room temperature. X-ray and differential centrifugal sedimentation analysis revealed that complete dehydration of amorphous aluminum hydroxide to aluminum oxyhydroxide is required to produce a stable adjuvant. Any residual amorphous aluminum hydroxide will spontaneously transform to crystalline aluminum hydroxide during aging at room temperature. Since crystalline aluminum hydroxide has a small surface area, the protein adsorption capacity of adjuvants containing amorphous aluminum hydroxide decreased by 30-40% when stored for 6 months at room temperature.
10
Rodney Tettenhorst, Douglas A. Hofmann · Clays and Clay Minerals · 1980 · 197 citations
Aluminum Compounds Used as Adjuvants in Vaccines
Suhag Shirodkar, Robert Hutchinson, D. Perry et al. · Pharmaceutical Research · 1990 · 161 citations
Aluminium compounds as adjuvants for vaccines and toxoids in man: a review.
Aprile Ma, Wardlaw Ac · PubMed · 1966 · 76 citations